UTC BioVenture Fund, operating as UCB Ventures, is an evergreen strategic corporate venture fund established in 2017 that invests in early-stage companies in the US and Europe. It focuses on novel therapeutic modalities and platforms addressing novel biology, particularly in next-generation cell and gene therapy, regenerative medicine, cell and tissue homeostasis, RNA modulation, oligo-based, and synthetic biology therapeutics. The firm aims for breakthrough innovations in areas adjacent to or b